Director Mark Johnson not standing for re-election; board class reconstitution announced

Cardlytics, Inc.

Mark Johnson will not stand for re-election at 2022 annual meeting; decision not due to disagreement.
Chris Suh nominated to move from Class III to Class I director; effective upon election at annual meeting.
Aimèe Lapic becomes Compensation Committee chair; John Balen moves from Audit to Compensation Committee.
Board to consist of three directors per class (I, II, III) after annual meeting.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mark Johnson

Director

CDLX · Cardlytics, Inc.

Filed: March 18, 2022, 7:59 PM ET

Mark Johnson provided notice to the board of directors (the “Board”) of Cardlytics, Inc. (the “Company”) of his decision to not stand for re-election at the Company’s 2022 annual meeting of stockholders (the “Annual Meeting”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Johnson departed as Director at Cardlytics, Inc..

Action: not stand for re-election
Role: Director

Exact text from the filing

Mark Johnson provided notice to the board of directors (the “Board”) of Cardlytics, Inc. (the “Company”) of his decision to not stand for re-election at the Company’s 2022 annual meeting of stockholders (the “Annual Meeting”).

View on SEC.gov

Cardlytics, Inc. filing history →

Source: SEC EDGAR

accession 0001666071-22-000027

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.